Moderna Inc
Marriott, Moderna and additional: CNBC’s ‘Halftime Report’ traders remedy your concerns
On Thursday’s “Ask Halftime,” our traders answered issues from CNBC Pro subscribers about stocks, bonds and ETFs all through this period of time of heightened sector volatility, together with regardless of whether to get, promote or hold specific names. Jason Snipe of Odyssey Money Advisors reviewed Marriott and why he expects there is continue to upside for […]
Read More
Merck revenue falls after dramatic drop in sales of Covid antiviral treatment
Medicine pill is seen with Merck logo displayed on a screen in the background in this illustration photo taken in Poland on October 4, 2021. NurPhoto | NurPhoto | Getty Images Merck on Thursday reported first-quarter revenue that fell 9% from the same period a year ago largely due to a steep drop in sales […]
Read More
Stocks making the biggest moves midday: Tesla, IBM, American Express, AT&T and more
Pedestrians walk through a street crossing in front of the American electric company car Tesla Motors official authorized car dealer store in Hong Kong, July 13, 2022. Budrul Chukrut | SOPA Images | Lightrocket | Getty Images Check out the companies making headlines in midday trading. Tesla — Shares tumbled nearly 9%. The action comes […]
Read More
Moderna teams up with IBM to put AI, quantum computing to work on mRNA technology used in vaccines
Sopa Images | Lightrocket | Getty Images Moderna and IBM are teaming up to use generative artificial intelligence and quantum computing to advance mRNA technology, the development at the core of the company’s blockbuster Covid vaccine, the companies announced Thursday. “We are excited to partner with IBM to develop novel AI models to advance mRNA […]
Read More
Abbott Labs shares pop as revenue, earnings defy steep drop in Covid test sales
The Abbott manufacturing facility in Sturgis, Michigan, on May 13, 2022. Jeff Kowalsky | AFP | Getty Images Shares of Abbott Laboratories popped Wednesday after the company’s earnings and revenue topped Wall Street’s expectations, defying a dramatic slowdown in sales of its Covid-19 tests. The medical products company posted adjusted earnings per share of $1.03. […]
Read More
Johnson & Johnson expects no new Covid vaccine revenue, after shots drive earnings beat
The Janssen Johnson & Johnson COVID-19 vaccine. Allen J. Schaben | Los Angeles Times | Getty Images International Covid vaccine sales helped spark Johnson & Johnson‘s revenue and earnings beat on Tuesday, but the company said it expects no sales from the shot moving forward. “Regarding our Covid-19 vaccine, we do not anticipate material sales […]
Read More
FDA authorizes additional omicron Covid booster for seniors and people with weak immune systems
Sylvester Fisher gets a influenza vaccine from pharmacist Patricia Pernal during an event hosted by the Chicago Department of Public Health at the Southwest Senior Center on September 09, 2022 in Chicago, Illinois. The vaccines were being offered along with pneumonia vaccines and the recently authorized COVID-19 booster vaccine, which protects against the original SARS-CoV-2 […]
Read More
Treasury yields minimal adjusted as concentration remains on economic outlook, earnings
John Zich | Bloomberg | Getty Visuals U.S. Treasury yields have been little changed on Tuesday, as traders continued to assess the outlook for the U.S. financial system and digested the most current spherical of company earnings. As of all around 5:25 a.m. ET, the yield on the benchmark 10-yr Treasury observe was fractionally higher […]
Read More
Stocks making the biggest moves midday: Alphabet, Charles Schwab, State Street, Moderna and more
In this article RXDX MTB STT SEDG FSLR ENPH SCHW RBLX MRNA Follow your favorite stocksCREATE FREE ACCOUNT People walk near the Google offices on July 04, 2022 in New York City. John Smith | View Press | Getty Images Check out the companies making headlines in midday trading. State Street, M&T Bank – Shares […]
Read More
Moderna shares fall despite promising data from cancer vaccine trial
Sopa Images | Lightrocket | Getty Images Shares of Moderna fell Monday as Wall Street chewed over new trial results on the personalized cancer vaccine it is developing with Merck. Merck’s shares were relatively flat. The experimental mRNA vaccine, when combined with Merck’s blockbuster drug Keytruda, cut the risk of recurrence of skin cancer melanoma […]
Read More